PRNewsWire · NVAX · October 29, 2026

Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe

Get the app for more

Explore stock news, insights and company research.